INREAL – Nintedanib for changes in dyspnea and cough in chronic PF-ILD patients in everyday clinical practice: a real-world evaluation* - Kreuter, M; Distler, J; Hechtner, M; Kondla, A; Koschel, D (Pneumologie, 2023)